NCT04592523View on ClinicalTrials.gov

A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South Korea

RecruitingOBSERVATIONAL
Enrollment

257

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

August 26, 2026

Study Completion Date

August 26, 2026

Conditions
Carcinoma, Non-Small-Cell LungAnaplastic Lymphoma Kinase
Interventions
OTHER

No Intervention

This is a non-interventional study.

Trial Locations (1)

49241

RECRUITING

Pusan National University Hospital, Busan

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY